ArticleCentral European journal of public health2022

Real-life experience in the effectiveness, impact on quality of life and safety of dupilumab treatment in patients with moderate to severe atopic dermatitis in the Czech Republic.

Milena Tánczosová et al.PubMed ↗Publisher ↗

No numbers read from the abstract.